Autologous specific dendritic cell therapy for Non-small cell lung cancer (Kaileon Biotechnology)
自体特异性树突状细胞治疗非小细胞性肺癌（凯立昂生物）
Report date: 2023/02/17 21:03:14
Base Information
Drug NameAutologous specific dendritic cell therapy for Non-small cell lung cancer (Kaileon Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesKaileon Biotechnology (Shanghai) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesKaileon Biotechnology (Shanghai) Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A